Navigation Links
The Female Health Company To Report First Quarter Operating Results on Wednesday, January 30, 2013
Date:1/23/2013

CHICAGO, Jan. 23, 2013 /PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO) today announced that it will host an investor conference call to discuss its operating results for the first quarter of FY2013 on Wednesday, January 30, 2013 at 11:00 a.m. Eastern Time (EST). The Company expects to report its operating results earlier the same day.

(Logo: http://photos.prnewswire.com/prnh/20120712/MM39764LOGO)

Shareholders and other interested parties may participate in the conference call by dialing 1-877-374-8416 (international participants dial 1-412-317-6716) and asking to be connected to "The Female Health Company Conference Call" a few minutes before 11:00 a.m. EST on January 30, 2013. 

A replay of the call will be available one hour after the call through 9:00 a.m. EST on Wednesday, February 6, 2013 by dialing 877-344-7529 (international callers dial 412-317-0088) and entering the conference ID # 10023963.  After February 6, 2013, the replay of the call will be available on the Company's website at www.femalehealth.com.

About The Female Health Company

The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in the U.S. and approximately 138 other countries globally. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued by the U.S., the European Union, Canada, Australia, South Africa, Japan, The People's Republic of China, Spain, Mexico, Greece, Turkey and
'/>"/>

SOURCE The Female Health Company
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
2. The Female Health Company Reports Second Quarter Operating Results
3. Attorneys for Class of Female VPs and SVPs Employed by PR Giant MSLGroup Clarify Companys Inaccurate Description of Federal Courts Recent Certification Ruling
4. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
5. The Female Health Company to Report FY2012 Operating Results on Tuesday, December 4, 2012
6. The Female Health Company Reports Record Fourth Quarter and FY2012 Operating Results
7. Nutrilys Del Mar Joins Health Forces With LAPD Underwater Dive Unit
8. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
9. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
10. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
11. Attendees Save Up To $800 on Global Healthcare Conferences in 2012 by Registering Through Global Information Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... February 27, 2015 ... Überwachungssystem für kongestive Herzinsuffizienz (CHF) in seiner ...     Die ... neuartiges Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz ... sie ein Finanzierungsvorhaben über 5 Mio. USD ...
(Date:2/27/2015)... NEW YORK , Feb. 27, 2015 ... DESI are increasing in applications as their ... research firm Kalorama Information.  Kalorama Information says ... MS) is the most powerful tool in ... (mass spec; MS) through its traditional techniques ...
(Date:2/26/2015)... Feb. 26, 2015  AbbVie (NYSE: ... studies in its neuroscience and oncology development programs ... th American Academy of Neurology annual meeting ... April 18-25. The accepted abstracts feature results from ... to investigational treatments in AbbVie,s pipeline. Presentations will ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... VEGAS, Jan. 9, 2012 BASIS Science, Inc. ( www.mybasis.com ... and health tracker, the Basis™ B1 band, will be demoing ... showing its web-based personal dashboard for the first time. The ... people information about their everyday health and wellness. ...
... the nation,s largest independent specialty pharmacy in the ... rights from Regeneron for its new drug EYLEA™ ... 2011, EYLEA (aflibercept) Injection was approved by the ... the treatment of neovascular (wet) age-related macular degeneration ...
Cached Medicine Technology:BASIS Science to Demo Basis Band at 2012 International CES; Reveals Design of Web Dashboard 2Diplomat Specialty Pharmacy to Provide Specialty Pharmacy Services for EYLEA™ (aflibercept) Injection 2
(Date:2/27/2015)... February 27, 2015 Clinovo, a leading ... validated Electronic Data Capture (EDC) at the CALBIO2015 ... March 2nd and March 3rd at Booth # 141. ... and DIY CRF and edit-check builder allowing Clinical Trials ... matter of days, without any programming experience. Clinovo’s new ...
(Date:2/27/2015)... honor of American Heart Month in February, Dr. Edwin Scott, from ... on how to improve heart health. , Heart disease may be ... to accept it as their fate. Although one may lack the ... sex or age — there are some key heart disease prevention ... to improve heart health and prevent heart disease: , 1. Don't ...
(Date:2/27/2015)... New York, NY (PRWEB) February 27, 2015 ... lawsuits ( http://www.lipitorlawsuitcenter.com/ ) that allege use of the ... Type 2 diabetes has issued a new order pertaining ... two bellwether trials, Bernstein Liebhard LLP comments. The Order, ... of South Carolina, on February 25th, directs the parties ...
(Date:2/27/2015)... On February 24 2015, Harper’s Bazaar Magazine posted ... that details the development of RT001, a form of topical ... FDA trials. For those afraid of needles, the idea of ... course, if the drug ultimately gets FDA approval it will ... goo.gl/PQvQwk) , “As the article notes, the size of the ...
(Date:2/27/2015)... The winter season is here, and with it ... grows, it can be harmful to the home and to ... of mold growth with the help of Enviro-Test. Enviro-Test, the ... the best ways to prevent mold during the winter months. ... for mold to thrive. Mold must be removed properly, otherwise ...
Breaking Medicine News(10 mins):Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Center for Primary Care Celebrates American Heart Month 2Health News:Center for Primary Care Celebrates American Heart Month 3Health News:Center for Primary Care Celebrates American Heart Month 4Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 2Health News:Federal Lipitor Litigation Issues New Order Pertaining to Discovery in Bellwether Cases, Bernstein Liebhard LLP Comments 3Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2
... Kuligowska-Noble, MD, FACR, a radiologist at Boston Medical Center ... School of Medicine (BUSM), is the recipient of the ... Women Radiologists. The award, which is presented annually to ... the field of radiology, was given to Kuligowska during ...
... , FRIDAY, Dec. 10 (HealthDay News) -- Frequent sex ... bliss as other newlyweds, a new study finds. , ... with relationships and marriage because they are more prone to ... published online in the journal Social Psychological and Personality ...
... team of researchers led by scientists from Johns Hopkins and ... appears to cause some instances of familial amyotrophic lateral sclerosis ... the more common form of this fatal neurodegenerative disease, which ... with ALS every year. Researchers don,t know exactly what ...
... strategy of blocking the growth of blood vessels with ... The growth of new blood vessels from pre-existing ... during wound healing and menstrual cycling, but is abundant ... disease frequently leading to blindness called age-related macular degeneration ...
... News) -- There,s no scientific evidence that stricter testing ... federal food and nutrition programs would improve the safety ... Council report released Thursday. The authors based their ... Agriculture,s Agricultural Marketing Service,s (AMS) program, which is used ...
... News) -- Only 50 percent of women over age 40 ... for breast cancer, even if they have insurance to cover ... database of more than 12 million people to review medical ... women included in the study had either employer-provided insurance or ...
Cached Medicine News:Health News:BMC radiologist receives 2010 Marie Sklodowska-Curie Award from AAWR 2Health News:Gene that causes some cases of familial ALS discovered 2Health News:A double block of blood vessels to starve cancerous tumors 2Health News:No Scientific Proof Backing Stricter Tests of Ground Beef in School Lunches 2Health News:Only Half of Women Over 40 Get Annual Mammograms 2
... etched into the gel tray which casts a ... cables, three 7x10 cm gel trays, 4 aluminum ... The Chameleon can accomodate up to five combs ... of 120 samples with a 2.5 cm path ...
... of a Separation-Control unit for system control ... gel staining. The optional PhastTransfer Kit quickly ... unit. Electrophoresis is performed on a thermostatic ... 0 to +70 C. Multi-step programming capability ...
... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
... 2000 apparatus and ready-to-use gels are the ... of nucleic acids by submerged gel electrophoresis. ... system, offering full compatibility and optimal performance, ... SEA 2000 and a unique staining tray, ...
Medicine Products: